Skip to content

Prospects of postoperative prostate cancer adaptive radiation therapy

Prospects of postoperative prostate cancer adaptive radiation therapy - Pro-ART

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
DRKS
Registry ID
DRKS00033235
Enrollment
29
Registered
2024-03-25
Start date
2024-03-01
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C61

Interventions

Group 1: Classic image-guided radiation therapy (Image-Guided Radiation Therapy, IGRT) with additional online adaptive radiation therapy (ART) Dosimetric and clinical evaluation of the effectiveness

Sponsors

Klinik und Poliklinik für Strahlentherapie des Universitätsklinikums Essen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with histologically confirmed, localized or locally advanced prostate cancer who are to receive postoperative radiotherapy of the prostate after an interdisciplinary tumor board decision and specialist assessment

Exclusion criteria

Exclusion criteria: Patients who cannot lie for longer than 15 minutes. Patients who are to receive radiotherapy of the lymphatic drainage are not included in this study.

Design outcomes

Primary

MeasureTime frame
The primary endpoint is to test the hypothesis, whether with standard PTV safety margins, ART provides dosimetric advantages over IGRT in more than 10% of patients with postoperative radiotherapy (H1).

Secondary

MeasureTime frame
The secondary endpoint is to evaluate, whether cases with an EUD<95% can be identified with the accumulated dose distribution early during the treatment series based on the EUD values for the individual fractions. Furthermore, the extent to which the planning safety margins around the CTV can be reduced to compensate for movements and deformations with online-adaptive radiotherapy (ART) compared to IGRT will be examined.

Countries

Germany

Contacts

Public ContactNika Guberina

Klinik und Poliklinik

nika.guberina@uk-essen.de+4920172382282

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 27, 2026